Since transgenic mice carrying additional copies of pmp22 displayed severe hypomyelination neuropathy, expressed embryonic SC markers, and incorporated BrdU, impaired SC differentiation into the myelinating status has been also proposed [66]. This evidence concerns the gene PMP22 and neuropathy.